Anti-Leukemic Activity of Luveltamab Tazevibulin (LT, STRO-002), a Novel Folate Receptor-a (FR-a)-Targeting Antibody Drug Conjugate (ADC) in Relapsed/Refractory CBF2AT3::GLIS2 AMLRobin Williams,Lane Miller,Stephanie Massaro, Elizabeth Krieger,Melinda Pauly, Catherine Nelson, Rebecca Johnson,Jennifer J. G. Welch,Deepa Bhojwani,Babak Moghimi, Philip Neff,Terzah M. Horton,Hamayun Imran,Raul C. Ribeiro,Terri L. Guinipero,Matthew A. Kutny, Felipe Bautista,Amy Johnson,Karen Lewing,Alan S. Gamis, Julienne Brackett,David McCall,Teena Bhatla,Maria Luisa Sulis, Amy Tellinghuisen, Jill C. Beck,Soheil MeshinchiBLOOD（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
